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THEME SERIES - UPR in Cancer 
Claudio Hetz1,2,3 and Eric Chevet4,5 
1Biomedical Neuroscience Institute, Faculty of Medicine, University of Chile, Santiago, Chile; 
2Institute of Biomedical Sciences, Center for Molecular Studies of the Cell, Santiago, Chile; 
3Department of Immunology and Infectious Diseases, Harvard School of Public Health, 
Boston MA 02115, USA; 4ER440 «Oncogenesis, stress & signaling», University of Rennes 1, 
F-35000, France; 5Centre de Lutte Contre le Cancer Eugène Marquis, F-35000 Rennes, 
France. (email: chetz@hsph.harvard.edu; chetz@med.uhile.cl and eric.chevet@inserm.fr)
Over the past decade endoplasmic reticulum (ER) stress signaling pathways have 
collectively emerged as an essential mechanism at the crossroads of the cellular functions 
involved in key steps of cancer development. ER stress signaling has pleiotropic roles in 
cancer, and is involved at the level of cell transformation, tumor growth and metastasis as 
well as resistance to chemo- and radio- therapy. Indeed beyond the instrumental roles of the 
ER in the biogenesis of secretory and transmembrane proteins, or in the control of lipid 
balance and calcium homeostasis, this sub-cellular compartment is now viewed as a signal 
integration platform that not only orchestrates ER homeostasis maintenance, but also 
controls the metabolic status of the cell, the cell interactions with its (micro)-environment, in 
addition to the global management of stress signals at the organ levels in whole organisms 
on a cell non-autonomous manner. 
Stress signals produce dramatic changes at the level of the ER membrane thereby eliciting 
the activation of select signaling pathways collectively known as the Unfolded Protein 
Response (UPR), which in turn reprogram the cell to either promote adaptation or eliminate 
irreversibly damaged cells by apoptosis. These functions associated with the biology of the 
ER have of course a significant impact on the understanding and treatment of complex 
disorders such as cancer. The field had suffered transforming changes in the last three years 
in the area of drug discovery, catalyzed by the identification of selective small molecules that 
can inhibit specific UPR signaling modules. Remarkably, an explosion of new studies in 
preclinical models of cancer have demonstrated that the pharmacological inhibition of two of 
the main UPR stress sensors (i.e. PERK and IRE1) have outstanding anticancer effects, 
which may even synergize with current chemotherapies available. Based on the emerging 
impact of the UPR to cancer, here we have coordinated an effort to overview the state-of-the-
art in the field and thus invited several leading experts to provide discussion articles for a 
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theme series on the UPR and Cancer. The aim is to integrate different visions and provide 
readers with current insights and to identify major unresolved questions. In this series, 10 
reviews articles focus on (i) the different cancer-associated stresses that elicit ER stress 
signaling pathways, highlighting the role of the microenvironment in solid tumors and its 
impact in cancer cell selection and transformation (Constantinos Koumenis [1]); (ii) the tools 
set in place by cancer cells to cope with stress and control proteostasis (Ted Hupp [2]; Serge 
Manié [3]; Ling Qi [4]); (iii) novel functions of the UPR in other aspects of cancer biology such 
as cell migration and genomic stability/DNA repair (Claudio Hetz [5]); (iv) the 
pharmacological molecules that were/are developed to block the IRE1 signaling pathway 
(Albert Koong [6]; Afshin Samali [7]); and finally (v) the biological impact of UPR signals on 
cancer cell immunogenicity (Guido Kroemer [8]; Patrizia Agostinis [9]), on tumor cell 
aggressiveness and invasion properties (Eric Chevet [10]) and, finally on the control of life 
and death decisions (Afshin Samali [7]). 
 We believe that readers will find the review articles in this Theme of interest and 
timely relevant. In addition, we hope that the concepts and evidence discussed in the articles 
will stimulate new avenues of research that hopefully will contribute to address unanswered, 
important questions regarding cellular mechanisms linking ER stress signaling and cancer 
biology. The new advances in the UPR field have demonstrated that strategies to target ER 
stress signaling with therapeutic agents such as small molecules is feasible in the context of 
cancer. In the short term, we hope some of these discoveries in preclinical models of cancer 
will translate into the development of novel clinical trials to fight this devastating disease. 
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Figure 1. The biological impact of the UPR on cancer biology. Summary of topics discussed 
in this review series highlighting the interconnection between ER stress signaling and distinct 
aspects of cancer. 
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